Zuellig Pharma 在韩国开设临床试验支持创新中心
The establishment of this innovation center in South Korea enhances the region's capacity for conducting cutting-edge clinical trials.
Opened a state-of-the-art Clinical Trial Support Innovation Center in South Korea.
Zuellig Pharma 在韩国揭幕了一个最先进的临床试验支持创新中心。该新设施旨在通过提供先进的基础设施和服务，来支持国内和全球的临床研究。该中心旨在加速药物开发过程，支持制药公司进行高效的试验，并为亚太地区医学研究的进步做出贡献。
The establishment of this innovation center in South Korea enhances the region's capacity for conducting cutting-edge clinical trials. It provides crucial support for pharmaceutical companies, potentially accelerating the availability of new medicines and therapies for patients in APAC and globally. This investment signifies a commitment to advancing medical research and development within the region.
The new center in South Korea strengthens APAC's position in global clinical research, offering advanced support for drug development and contributing to the region's growing role in medical innovation.
此信号在行业全局中的位置。
https://www.zuelligpharma.com/news-insights/Zuellig-Pharma-unveils-state-of-the-art-Clinical-Trial-Support-Innovation-Center-in-South-Korea-to-support-both-domestic-and-global-clinical-research-needs
阅读完整来源精选情报直达收件箱。无垃圾邮件，随时退订。
登录后可保存信号笔记。
登录